Record

RefNoEC/2015/08
LevelItem
TitleCollins, Rory Edwards: certificate of election to the Royal Society
Date30 April 2015
DescriptionCertificate of Candidate for Election to the Fellowship
CitationSir Rory Collins, BHF Professor of Medicine and Epidemiology, Nuffield Department of Population Health, University of Oxford

Rory Collins created and led large studies that transformed statins from esoteric drugs for familial hypercholesterolaemia into safe, widely-used generics that annually prevent millions of heart attacks and ischaemic strokes. His large placebo-controlled trials and worldwide Cholesterol Treatment Trialists' meta-analyses confirmed heart attack reduction, discovered stroke reduction, and demonstrated safety (RR=1 for non-vascular deaths in the randomised trials) and efficacy in many different types of patient. Remarkably, his CTT still gets all rival trials periodically to share their detailed datasets with him; comparing different regimens, benefit is proportional to cholesterol reduction from top to bottom of the 'normal' cholesterol range.
Extent5p
FormatPrinted
AccessStatusClosed
Add to My Items

    Collection highlights

    Browse the records of some of our collections, which cover all branches of science and date from the 12th century onwards. These include the published works of Fellows of the Royal Society, personal papers of eminent scientists, letters and manuscripts sent to the Society or presented at meetings, and administrative records documenting the Society's activities since our foundation in 1660.

    The Royal Society

    The Royal Society is a Fellowship of many of
    the world's most eminent scientists and is the
    oldest scientific academy in continuous existence.
    Registered charity number 207043

    Website design ©CalmView



    CONTACT US

    + 44 207 451 2500
    (Lines open Mon-Fri, 9:00-17:00. Excludes bank holidays)

    6-9 Carlton House Terrace, London SW1Y 5AG

    Email Us →

    SUBSCRIBE

    Subscribe to our newsletters to be updated with the
    latest news on innovation, events, articles and reports.

    Subscribe →

    © CalmView